(±)-Blebbistatin - CAS 674289-55-5
Category: Inhibitor
Please be kindly noted products are not for therapeutic use. We do not sell to patients.
Molecular Formula:
C18H16N2O2
Molecular Weight:
292.34
COA:
Inquire
Targets:
Myosin
Description:
(±)-Blebbistatin is a selective inhibitor of myosin II ATPase. It reversibly blocks cell blebbing, and disrupts directed cell migration and cytokinesis in vertebrate cells; inhibits contraction of the cleavage furrow without disrupting mitosis or contractile ring assembly.
Brife Description:
myosin II ATPase inhibitor
Purity:
≥98% by HPLC
Related CAS:
1177356-70-5 (L-enantiomer)
Synonyms:
Blebbistatin; (±)-1,2,3,3a-Tetrahydro-3a-hydroxy-6-methyl-1-phenyl-4H-pyrrolo[2,3-b]quinolin-4-one
MSDS:
Inquire
InChIKey:
LZAXPYOBKSJSEX-UHFFFAOYSA-N
InChI:
InChI=1S/C18H16N2O2/c1-12-7-8-15-14(11-12)16(21)18(22)9-10-20(17(18)19-15)13-5-3-2-4-6-13/h2-8,11,22H,9-10H2,1H3
Canonical SMILES:
CC1=CC2=C(C=C1)N=C3C(C2=O)(CCN3C4=CC=CC=C4)O
1.Control of neurite outgrowth and growth cone motility by phosphatidylinositol-3-kinase.
Tornieri K;Welshhans K;Geddis MS;Rehder V Cell Motil Cytoskeleton. 2006 Apr;63(4):173-92.
Phosphatidylinositol-3-kinase (PI-3K) has been reported to affect neurite outgrowth both in vivo and in vitro. Here we investigated the signaling pathways by which PI-3K affects neurite outgrowth and growth cone motility in identified snail neurons in vitro. Inhibition of PI-3K with wortmannin (2 microM) or LY 294002 (25 microM) resulted in a significant elongation of filopodia and in a slow-down of neurite outgrowth. Experiments using cytochalasin and blebbistatin, drugs that interfere with actin polymerization and myosin II activity, respectively, demonstrated that filopodial elongation resulting from PI-3K inhibition was dependent on actin polymerization. Inhibition of strategic kinases located downstream of PI-3K, such as Akt, ROCK, and MEK, also caused significant filopodial elongation and a slow-down in neurite outgrowth. Another growth cone parameter, filopodial number, was not affected by inhibition of PI-3K, Akt, ROCK, or MEK. A detailed study of growth cone behavior showed that the filopodial elongation induced by inhibiting PI-3K, Akt, ROCK, and MEK was achieved by increasing two motility parameters: the rate with which filopodia extend (extension rate) and the time that filopodia spend elongating.
2.The catch state of mollusc catch muscle is established during activation: experiments on skinned fibre preparations of the anterior byssus retractor muscle of Mytilus edulis L. using the myosin inhibitors orthovanadate and blebbistatin.
Andruchov O;Andruchova O;Galler S J Exp Biol. 2006 Nov;209(Pt 21):4319-28.
Catch is a holding state of muscle where tension is maintained passively for long time periods in the absence of stimulation. The catch state becomes obvious after termination of activation; however, it is possible that catch linkages are already established during activation. To investigate this, skinned fibre bundles of the anterior byssus retractor muscle of Mytilus edulis were maximally activated with Ca(2+) and subsequently exposed to 10 mmol l(-1) orthovanadate (V(i)) or 5 mumol l(-1) blebbistatin to inhibit the force-generating myosin head cross-bridges. Repetitive stretches of about 0.1% fibre bundle length were applied to measure stiffness. Inhibitor application depressed force substantially but never resulted in a full relaxation. The remaining force was further decreased by moderate alkalization (change of pH from 6.7 to 7.4) or by cAMP. Furthermore, the stiffness/force ratio was higher during exposure to V(i) or blebbistatin than during partial Ca(2+) activation producing the same submaximal force. The increased stiffness/force ratio was abolished by moderate alkalization or cAMP. Finally, the stretch-induced delayed force increase (stretch activation) disappeared, and the force recovery following a quick release of the fibre length, was substantially reduced when the force was depressed by V(i) or blebbistatin.
3.Characterization of Blebbistatin Inhibition of Smooth Muscle Myosin and Nonmuscle Myosin-2.
Zhang HM;Ji HH;Ni T;Ma RN;Wang A;Li XD Biochemistry. 2017 Aug 15;56(32):4235-4243. doi: 10.1021/acs.biochem.7b00311. Epub 2017 Aug 1.
Blebbistatin is a potent and specific inhibitor of the motor functions of class II myosins, including striated muscle myosin and nonmuscle myosin-2 (NM2). However, the blebbistatin inhibition of NM2c has not been assessed and remains controversial with respect to its efficacy with smooth muscle myosin (SmM), which is highly homologous to NM2. To clarify these issues, we analyzed the effects of blebbistatin on the motor activities of recombinant SmM and three NM2s (NM2a, -2b, and -2c). We found that blebbistatin potently inhibits the actin-activated ATPase activities of SmM and NM2s with following IC;50; values: 6.47 μM for SmM, 3.58 μM for NM2a, 2.30 μM for NM2b, and 1.57 μM for NM2c. To identify the blebbistatin-resistant myosin-2 mutant, we performed mutagenesis analysis of the conserved residues in the blebbistatin-binding site of SmM and NM2s. We found that the A456F mutation renders SmM and NM2s resistant to blebbistatin without greatly altering their motor activities or phosphorylation-dependent regulation, making A456F a useful mutant for investigating the cellular function of NM2s.
Molecular Weight Calculator Molarity Calculator Solution Dilution Calculator

Related Myosin Products


CAS 1576-37-0 BTS

BTS
(CAS: 1576-37-0)

A potent inhibitor of skeletal muscle Ca2+-stimulated myosin S1 ATPase (IC50 approx. 5uM) activity. Reversible blocks the gliding motility. Also weakens myosin’...

CAS 674289-55-5 (±)-Blebbistatin

(±)-Blebbistatin
(CAS: 674289-55-5)

(±)-Blebbistatin is a selective inhibitor of myosin II ATPase. It reversibly blocks cell blebbing, and disrupts directed cell migration and cytokinesis in verte...

CAS 1642288-47-8 MYK-461

MYK-461
(CAS: 1642288-47-8)

MYK-461 is a myosin inhibitor that selectively decreases the ATPase activity of cardiac myosin heavy chain, thus it is potentially for the treatment of hypertro...

CAS 224579-74-2 MLCK inhibitor peptide 18

MLCK inhibitor peptide 18
(CAS: 224579-74-2)

A myosin light chain kinase (MLCK) inhibitor (IC50= 50 nM), and inhibits CaM kinase IIonly at 4000-fold higher concentrations.

CAS 873697-71-3 Omecamtiv mecarbil

Omecamtiv mecarbil
(CAS: 873697-71-3)

Omecamtiv mecarbil is a cardiac-specific myosin activator with an EC50 of 0.6 μM.

CAS 110448-33-4 ML-7 hydrochloride

ML-7 hydrochloride
(CAS: 110448-33-4)

ML-7 Hcl is a cell-permeable, potent, reversible, ATP-competitive, and selective inhibitor of myosin light chain kinase (Ki = 300 nM). It also inhibt smooth-mus...

CAS 1177356-70-5 (+)-Blebbistatin

(+)-Blebbistatin
(CAS: 1177356-70-5)

(+)-Blebbistatin is the inactive enantiomer of Blebbistatin, an inhibitor of myosin II ATPase. (+)-Blebbistatin can be used as a negative control of the active ...

Chemical Structure

CAS 674289-55-5 (±)-Blebbistatin

Quick Inquiry

Verification code

Featured Items